-+ 0.00%
-+ 0.00%
-+ 0.00%

BNP Paribas Initiates Swedish Orphan Biovitrum at Underperform

MT Newswires·07/01/2025 08:50:41
Listen to the news
08:50 AM EDT, 07/01/2025 (MT Newswires) -- BNP Paribas on Monday began its coverage of biopharmaceutical company Swedish Orphan Biovitrum (SOBI.ST) with an underperform rating and a price target of 275 kronor. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)